OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 17 of the 34 sources its claims cite were checked for support.
Abstract
OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years. Participants include 605 cognitively normal adults and 493 individuals at various stages of cognitive decline ranging in age from 42 to 95 years. The OASIS-3 dataset contains over 2000 MR sessions, including multiple structural and functional sequences. PET metabolic and amyloid imaging includes over 1500 raw imaging scans and the accompanying post-processed files from the PET Unified Pipeline (PUP) are also available in OASIS-3. OASIS-3 also contains post-processed imaging data such as volumetric segmentations and PET analyses. Imaging data is accompanied by dementia and APOE status and longitudinal clinical and cognitive outcomes. OASIS-3 is available as an open access data set to the scientific community to answer questions related to healthy aging and dementia.
Overview
CoChat Summary
TL;DR
OASIS-3 is an open-access compilation of longitudinal MRI, PET, clinical, and cognitive data from 1098 participants collected over 15 years at the Washington University Knight ADRC, spanning cognitively normal aging and early-stage Alzheimer disease. The paper describes the dataset's contents, processing pipelines (FreeSurfer, PUP, Centiloid), and exploratory analyses demonstrating feasibility of volumetric and amyloid analyses.
Key findings
- The release includes 1098 participants aged 42.5–95.6 years: 605 cognitively normal adults and 493 at various stages of cognitive decline; 850 entered with CDR 0 (605 remained normal, 245 converted), and 248 entered with CDR > 0. The APOE ε4 allele was present in 439 participants.
- Imaging inventory: 2168 MR sessions (236 at 1.5T, 1932 at 3T) and 1608 PET sessions (999 PiB, 492 Florbetapir/AV45, 117 FDG); 1912 FreeSurfer segmentations passed QC, and PUP post-processing was included for 1356 PET sessions.
- Exploratory analyses showed a significant baseline whole-brain volume group difference (F(2,974) = 32.36, p < 0.001), with greater annual atrophy in those entering with dementia (−2.01%/year, SD = 2.15) and converters (−1.68%/year, SD = 1.91) versus stable controls (−1.13%/year, SD = 1.49).
- Baseline amyloid differed significantly across groups (F(2,724) = 191.39, p < 0.001), but rate of amyloid deposition did not differ (F(2,330) = 0.19, p > 0.05); baseline amyloid correlated with later conversion while baseline whole-brain volume did not.
Methods
- Design: data descriptor compiling participants from several ongoing Knight ADRC studies (Memory and Aging Project, Adult Children Study, Healthy Aging and Senile Dementia) recruited over 15 years, with clinical/cognitive assessments standardized via the Uniform Data Set (UDS) and dementia staged by CDR.
- Data: structural and functional MRI (T1w, T2w, FLAIR, DTI, BOLD, ASL, SWI, TOF, fieldmaps), amyloid (PiB, AV45) and metabolic (FDG) PET, APOE genotyping, and longitudinal clinical/cognitive outcomes; images converted to NIfTI/BIDS and de-identified.
- Analysis: MRI processed with FreeSurfer for volumetric segmentation; PET processed with the PET Unified Pipeline (PUP) including partial volume correction and Centiloid standardization; exploratory group comparisons (stable controls, converters, dementia at entry) used ANOVA and t-tests on whole-brain volume and amyloid measures.
Limitations
- Stated: a standardized visit structure was not maintained across data collection, so investigators must use "days from entry" or "age at visit" to link imaging and clinical visits, and no association between visits was imposed; there is no categorical variable indicating healthy versus Alzheimer Disease status.
- Stated: the published OASIS datasets (Cross-sectional, Longitudinal, OASIS-3) contain overlapping participant data and should never be combined or aggregated, and links across datasets cannot be provided.
- Evident from the text: the exploratory analyses are described by the authors as "cursory" and "exploratory descriptive analyses" rather than confirmatory tests, and imaging was acquired across multiple scanner models and field strengths over 10+ years.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 80 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Quality control reviewed post-processing PUP output 42,43 , which includes uptake measure for FreeSurfer-based regions, was included for 1356 PET sessions.”
What the sources say
- Partly supportedcites [42] sourceExperimental — accuracy not yet measured
The Image Analysis section (page unavailable) describes quality assurance of FreeSurfer segmentation and PET uptake measures for FreeSurfer-defined regions, supporting the description of the output. It does not identify that output as PUP; the 1356-session count describes the citing authors’ dataset, not a result attributed to this source. (LLM, conf=0.78)
- Supportedcites [43] source
The Software section describes a FreeSurfer-based PET quantification workflow with output data types and quality-control reports. The FreeSurfer based analysis section describes quantitative measurements from FreeSurfer-defined regions. The citation supports the description of the processing output; the 1,356-session count describes the citing study’s own data, not a result attributed to this source. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Centiloid values 53 have been provided to standardize values across amyloid tracers PiB and Florbetapir.”
What the sources say
- Partly supportedcites [53] 2018, Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies, NeuroImage Clin sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says the Centiloid scale puts measurements on a common scale to facilitate comparisons between tracers. The Methods describe Centiloid conversion for PiB measurements in GAAIN and Knight ADRC data, but the paper does not say that it provided Centiloid values for both PiB and florbetapir in OASIS-3. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years.”
plainn = 1,098- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OASIS-3 also contains post-processed imaging data such as volumetric segmentations and PET analyses.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The published OASIS datasets - OASIS Cross-sectional, OASIS Longitudinal, and OASIS-3 - contain overlapping participant data and should never be combined or aggregated.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
35 more claims
Create a free account to see all 100 claims and every source verdict.
- It may state two separate claims as one. 27
- Probably not a substantial claim. 45
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“we utilize cognitively normal data from the Open Access Series of Imaging Studies - 3 (OASIS3) (LaMontagne et al., 2019) and the Alzheimer's Disease Neuroimaging Initiative (ADNI) (Alzheimer's Disease Neuroimaging Initiative (ADNI), 2004) datasets, as they are free from major brain pathologies and artifacts.”
From IterMask3D: Unsupervised Anomaly Detection and Segmentation with Test-Time Iterative Mask Refinement in 3D Brain MR (2025) · cites this paper as LaMontagne et al., 2019
Experimental — accuracy not yet measured
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“t (370) = 3.02, p = 0.002”
Reported p = .002 · recomputed p = .003
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upt(370) = 3.02reported p = .002 · recomputed p = .003
“t (370) = 3.02, p = .002”
- ConsistentF(2, 974) = 32.36reported p < .001 · recomputed p < .001
“F(2,974) = 32.36, p < .001”
- Consistentt(749) = 7.98reported p < .001 · recomputed p < .001
“t (749) = 7.98, p < .001”
- Consistentt(424) = 5.77reported p < .001 · recomputed p < .001
“t (424) = 5.77, p < .001”
- Consistentt(771) = 1.54reported p = .125 · recomputed p = .124
“t (771) = 1.54, p = .125”
8 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exploratory MRI and PET Analyses · p. 22
“Dementia at aging started in the study with CDR > 0.”
§ Exploratory MRI and PET Analyses · p. 23
“Those who entered the study with dementia (defined as CDR > 0.5) had significantly higher amyloid levels”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Data description · p. 20
“OASIS-3 includes 1608 PET imaging sessions comprised of 999 PiB, 492 Florbetapir (AV45), and 117 FDG scans (Table 4).”
§ Data description · p. 20
“| PIB | 1000 | 937 |”
Citations
Cites
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · cited 1×
“In the Trail Making Test participants were asked to make a trail by connecting a series of numbers (1-26) for part A and connecting a series of alternating numbers and letters (1-A-2-B) for part B.”
Self-citationFischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
The organization of the human cerebellum estimated by intrinsic functional connectivity
Buckner, R. L., Krienen, F. M., Castellanos, A., Diaz, J. C., & Yeo, B. T. T. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00339.2011 · Cited by 7,304 · cited 1×
“…development of neuroimaging tools, such as brain atlases 3,4 , tissue segmentation algorithms 5 , and de-identification tools 6 , used to create models of healthy aging 7,8 and AD timecourse 7–11 , used to answer hypothesis driven questions 12,13 , and used for educational and training purposes.”
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147 · cited 2×
“…cortical models are complete, a number of deformable procedures were performed for further data processing and analysis including surface inflation (Fischl et al., 1999a), registration to a spherical atlas which is based on individual cortical folding patterns to match cortical geometry across…”
BackgroundMethodMeasuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,818 · cited 2×
“…white matter boundary, automated topology correction 25,36 , and surface deformation following intensity gradients to optimally place the gray/white and gray/cerebrospinal fluid borders at the location where the greatest shift in intensity defines the transition to the other tissue class 23,24 .”
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“In the Trail Making Test participants were asked to make a trail by connecting a series of numbers (1-26) for part A and connecting a series of alternating numbers and letters (1-A-2-B) for part B.”
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“…matter and deep gray matter volumetric structures (including hippocampus, amygdala, caudate, putamen, ventricles) 26,27 intensity normalization 35 , tessellation of the gray matter white matter boundary, automated topology correction 25,36 , and surface deformation following intensity…”
Cited by
Medical image segmentation using deep learning: A survey
Wang, R., Lei, T., Cui, R., Zhang, B., Meng, H., & Nandi, A. K. (2022) · IET Image Processing · doi:10.1049/ipr2.12419 · Cited by 892
Diffusion models in medical imaging: A comprehensive survey
Kazerouni, A., Aghdam, E. K., Heidari, M., Azad, R., Fayyaz, M., Hacihaliloglu, I., & Merhof, D. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102846 · Cited by 765
Federated learning for medical image analysis: A survey
Guan, H., Yap, P.-T., Bozoki, A., & Liu, M. (2024) · Pattern Recognition · doi:10.1016/j.patcog.2024.110424 · Cited by 518
Multimodal deep learning for Alzheimer's disease dementia assessment
Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31037-5 · Cited by 420
Li, J., Chen, J., Tang, Y., Wang, C., Landman, B. A., & Zhou, S. K. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102762 · Cited by 389
Metadata
- Authors
- LaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., Raichle, M. E., Cruchaga, C., & Marcus, D.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- LaMontagne, Pamela J.
- ORCID
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2019-12-15
- OpenAlex
- W2995808388
- Cited by
- 779
- References
- 62
- Citations by year
- 2026: 98 · 2025: 158 · 2024: 155 · 2023: 142 · 2022: 125 · 2021: 73 · 2020: 27
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nd
- Locations
- medRxiv (acceptedVersion, cc-by-nd)
- Funders
- Eli Lilly and Company
- National Institutes of Health (P30 NS09857781, UL1TR000448, P50 AG00561)
- Avid Radiopharmaceuticals
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis (P01AG003991)
- National Institute on Aging (R01AG043434, P01AG003991, P01AG026276)
- National Institute of Biomedical Imaging and Bioengineering (R01EB009352)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Keywords
- OASIS-3, Alzheimer's disease, normal aging, cognitive decline, longitudinal neuroimaging, structural MRI, functional MRI, positron emission tomography, amyloid imaging, glucose metabolism, 3D image segmentation, dementia, apolipoprotein E, cognitive outcomes, healthy aging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease. https://app.cochat.ai/papers/10.1101/2019.12.13.19014902
- The paper
- LaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., Raichle, M. E., Cruchaga, C., & Marcus, D. (2019). OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease. medRxiv. https://doi.org/10.1101/2019.12.13.19014902
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.